Skip to main content
Erschienen in: Techniques in Coloproctology 11/2017

Open Access 17.11.2017 | Original Article

The impact of the national bowel screening program in the Netherlands on detection and treatment of endoscopically unresectable benign polyps

verfasst von: C. C. M. Marres, C. J. Buskens, E. Schriever, P. C. M. Verbeek, M. W. Mundt, W. A. Bemelman, A. W. H. van de Ven

Erschienen in: Techniques in Coloproctology | Ausgabe 11/2017

Abstract

Background

In January 2014, a national bowel cancer screening program started in the Netherlands. The program is being implemented in phases until 2019. Due to this program, an increase in patients referred for a colorectal resection for benign, but endoscopically unresectable polyps, is expected. So far, most resections are performed according to oncological principles despite no pre-operative histological diagnosis of malignancy. The aim of this study was to analyze the increase in referred patients during the first year of the screening program and to compare pathological results and clinical outcome of resections of patients undergoing resection for benign polyps before and after implementation of screening.

Methods

Patients referred for colorectal resection without biopsy-proven cancer between January 2009 and January December 2014 were identified from a prospectively maintained database. Patients with endoscopically macroscopic features of carcinoma were excluded.

Results

Seventy-six patients were included. Forty-seven patients (61.8%) were operated on in the 5 years prior to implementation of the screening program, and 29 patients (38.2%) were operated during the first year of implementation of the screening program. The overall malignancy rate before the introduction of the program was 14.1 and 6.6% after it had started (p = .469). All resections were performed laparoscopically; the conversion rate was 3.9% (n = 3). The overall mortality rate was 2.7% (n = 2), major complications (Clavien–Dindo > 3b) occurred in 11.8% (n = 9) of patients. The anastomotic leakage rate was 3.9% (n = 3).

Conclusions

The number of patients referred for benign polyps tripled after introduction of the screening program. With an overall major morbidity and mortality rate of 11.8%, it seems valid to discuss whether an endoscopic excision with advanced techniques with or without laparoscopic assistance would be preferable in this patient group, accepting a 6.6% reoperation rate for additional oncological resection with lymph node sampling in patients in whom a malignancy is found on histological analysis of the complete polyp.

Introduction

In January 2014, a national bowel cancer screening program started in the Netherlands. This program is for men and women in the age group 55–75 years, and it is being implemented in phases between 2014 and 2019. The population screening is performed by immunological fecal occult blood testing, with subsequent colonoscopy if tests results are positive [1]. During colonoscopy, polyps are removed and biopsies are taken from lesions in the colon. Since polyps may progress to cancer over a period of time, this contributes to the prevention and early detection of colorectal cancer [2, 3]. From the bowel screening program in England, we know that cancer and higher risk adenomas were found in 11.6 and 43% of men and 7.8 and 29% of women, respectively [4].
The current treatment for patients with endoscopically unresectable polyps is to perform an oncological colorectal resection. However, a more radical mesenteric resection is generally associated with increased morbidity and mortality compared to a smaller resection, and these complications should therefore be weighed against the chance of preventing cancer [5]. Brigic et al. [6] remarked that clinical outcomes following oncologic resection for benign colonic polyps are poorly documented. Their prospective case controlled study showed similar postoperative complication rates after colonic resections for benign and malignant colonic polyps (46 and 31%, respectively).
Due to the introduction of the national screening program, an increase in patients referred for a segmental colectomy for benign, but endoscopically unresectable polyps, is expected. The aim of this study was to assess the impact on daily clinical practice of this increase and to compare pathological results to clinical outcome of resections.

Materials and methods

This study is a retrospective cohort study from a prospectively maintained database. Medical records of consecutive patients, who underwent an oncological colorectal resection between January 2009 and December 2014 in our institution, were reviewed. Patients with polyps referred for surgery without microscopically proven cancer were identified. Exclusion criteria were macroscopic features of malignant degeneration noticed by the endoscopist during colonoscopy, masses that could not be passed with the endoscope and patients undergoing laparoscopic local excision.
Patient characteristics were assembled, including age, gender, body mass index (BMI), American Society of Anesthesiologists (ASA) classification and comorbidities. Information on preoperative and postoperative polyp pathology, type of surgery, postoperative complications and mortality were analyzed.
Resectability of a polyp was assessed by the endoscopist (expert opinion). Biopsies were taken during endoscopy in every patient. All patients were discussed in the weekly multidisciplinary gastrointestinal oncology meeting. All colorectal resections were performed laparoscopically by, or under supervision of, a specialized colorectal surgeon. Postoperatively, patients were managed according to the enhanced recovery after surgery (ERAS) fast track protocol [7]. Complications were graded according to the Clavien–Dindo classification [8], and major complications were defined as grade 3b or higher. Histological examination of the resected specimen and lymph node assessment were performed by pathologists according to a standardized protocol.

Statistical analysis

Statistical analysis was performed using SPSS software, version 22.0 (SPSS Inc, Chicago, IL, USA).
Continuous variables were presented as mean values with a standard deviation (SD) or as median values with an interquartile range (IQR) according to the distribution. Discrete variables were presented as counts and percentages. Categorical data were compared between groups using the Chi-square test, and continuous data were compared using the independent samples t test or Mann–Whitney U test. A two-tailed p value of < 0.05 was considered statistically significant.

Results

Patient demographics

A total of 674 patients had an oncological colorectal resection between January 2009 and December 2014. Seventy-six patients met the inclusion criteria and were analyzed. Patients were predominantly male (56.5%) with a mean age of 65 years (range 38–82, SD 9.8). In 9 patients (11.8%), an invasive carcinoma was found after histological analysis of the resected specimen. Preoperative clinicopathologic characteristics of patients and polyps are summarized in Table 1.
Table 1
Characteristics of patients and polyps
Demographic
Total
N = 76 (%*)
Benign
N = 67 (%*)
Malignant
N = 9 (%*)
p value
Age (years)
   
.739**
 Median
65 (9.8)
66
63
 
 Range
38–82
38–82
39–72
 
Sex
   
.723***
 Female
33 (43.4)
30 (44.8)
3 (33.3)
 
 Male
43 (56.6)
37 (55.2)
6 (66.7)
 
BMI
   
.931**
 Average (SD)
27.08 (4.4)
27.03 (4.3)
27.44 (4.2)
 
 Range
17.94–38.20
17.94–38.20
22.82–35.16
 
ASA classification
   
.757***
 ASA 1
25 (32.9)
22 (32.8)
3 (33.3)
 
 ASA 2
42 (55.3)
36 (53.7)
6 (66.7)
 
 ASA 3
7 (9.2)
7 (10.4)
 
 ASA 4
1 (1.3)
1 (1.5)
 
Type of operation
   
.009***
 Right colectomy
45 (59.2)
44 (65.7)
1 (11.1)
 
 Left colectomy
8 (10.5)
4 (6.0)
4 (44.4)
 
 Sigmoidectomy/LAR
19 (25.0)
16 (23.9)
3 (33.3)
 
 Total colectomy
2 (2.6)
1 (1.5)
1 (11.1)
 
 Ileocaecal resection
2 (2.6)
2 (3.0)
 
Preoperative histology
   
.024***
 Tubulovillous
47 (62.3)
44 (65.7)
3 (33.3)
 
 Tubular
10 (13.0)
10 (14.9)
 
 Villous
7 (9.1)
4 (6.0)
3 (33.3)
 
 Other
10 (13.0)
7 (10.4)
3 (33.3)
 
 Unknown
2 (2.6)
2 (3.0)
 
Dysplasia
   
.624***
 Low grade
33 (43.4)
30 (44.8)
3 (33.3)
 
 High grade
13 (17.1)
11 (16.4)
2 (22.2)
 
 Unknown
30 (39.3)
26 (38.8)
4 (44.4)
 
Total
76 (100)
67 (100)
9 (100)
 
BMI body mass index, ASA American Society of anesthesiologists, LAR low anterior resection
* Unless otherwise stated in the first column
** Mann–Whitney U test
*** Chi-square test

Outcome

Forty-seven of the 76 patients (61.8%) were operated on before the start of the screening program in 2014, and 29 patients (38.2%) after it had begun. All resections were planned as laparoscopic procedures, with a conversion rate of 3.9% (n = 3). A (nonsignificant) decrease in the percentage of malignant polyps was seen in patients treated in 2014 compared to the pre-screening cohort (7/47 = 14.9 vs. 2/29 = 6.9%, respectively) (p = .469).
Malignant polyps were found significantly more often after left sided colectomies versus other resections (44.4 vs. 10.4%, respectively, p < .001), whereas there was no significant difference in preoperative histological characteristics.
Although numbers were too small to compare tumor stage before and after the introduction of the program, it is noteworthy that all but 1 patient had early carcinoma without lymph nodes metastases (Table 2).
Table 2
Postoperative characteristics of invasive cancer
 
N = 9 (%)
T stage
 T1
5 (55.6)
 T2
3 (33.3)
 T3
1 (11.1)
N stage
 N0
8 (88.9)
 N1
1 (11.1)
Total
9 (100)

Complications

The overall mortality rate was 2.6% (n = 2). Major complications (Clavien–Dindo > 3b) occurred in 9 patients (11.8%), with an anastomotic leakage rate of 3.9% (n = 3). Minor complications (Clavien–Dindo < 3b) occurred in 21.0% (n = 15) of patients (Table 3).
Table 3
Perioperative complications
Complications
N (%)
Perioperative death
2 (2.6)
Complication Clavien–Dindo > 3b
9 (11.8)
Complication Clavien–Dindo < 3b
16 (21.0)
Anastomotic leak
3 (3.9)
Conversion
3 (3.9)
Total
76 (100)

Discussion

The number of patients referred for laparoscopic colorectal resection for benign polyps almost tripled after introduction of the national screening program in our country; 29 patients were operated on in 1 year (2014) compared to 47 patients in 5 years (2009–2013). Since the program is being introduced in phases, the number of patients referred for surgery after colonoscopy will most likely increase.
The malignancy rate dropped from 14.9 to 6.9% (nonsignificant difference), and apart from location (left sided), there were no predictive parameters for malignancy. Previous studies also showed a decrease in malignancy rate in polyps detected in a screening program. Patients from the UK bowel cancer screening program were more likely to have larger adenomatous polyps compared to the symptomatic population [4, 9, 10]. The underlying reasons for the differing profiles of polyps remain speculative, but this could also be an explanation for our decrease in the malignancy rate.
Multiple studies have shown that in the past endoscopists were not always experienced enough in differentiating benign from potentially malignant polyps. However, in recent years more training and the use of polyp classifications (e.g., Kudo pattern [11]) have increased their knowledge of the characteristics of a malignant polyp. The decline of the percentage of malignant polyps might also be explained by the improvement in this preoperative differentiation and the ongoing improvement in endoscopists’ ability to recognize malignant polyps.
Endoscopic submucosal dissection (ESD) is an advanced endoscopic technique that allows en bloc resection of gastrointestinal tumors [12], and implementing training of European endoscopists in ESD could have an important role in this setting.
Previous studies analyzing the incidence of malignancies in endoscopically unresectable polyps consequently recommend laparoscopic oncological resection and report malignancy rates in polyps varying from 8 to 22% [1320] (Table 4). The morbidity and mortality reported in these studies were often poorly defined or not mentioned. The complication rate in the present study is consistent with the complication rates found in the total population undergoing colorectal surgery in the Netherlands [21]. In the largest study on unresectable polyps, Bertelson et al. [13] suggest that polyp size and villous features do not strongly predict malignancy, which seems consistent with the results of our study. They confirm that polyps located in the left colon are more likely to harbor cancer. Based on their findings, they suggest that endoscopically unresectable polyps are best treated by radical oncologic resection, but they do not describe morbidity or mortality in their population.
Table 4
Previous studies reporting the incidence of malignancy in endoscopically unresectable polyps thought to be being before resection with associated complication rates
Author
N patients
Malignancy rate (%)
Complications
Anastomotic leak
Mortality
Bertelson et al. [13]
750
17
Not mentioned
Not mentioned
Not mentioned
Loungnarath et al. [14]
165
13
23%
2.6%
2.6%
Hauenschild et al. [15]
58
0
9.3%
Not mentioned
0%
Itah et al. [16]
64
14
4%
1.7%
0%
Benedix et al. [17]
525
18
20.8%
3.6%
0.9%
Zmora et al. [18]
38
18
10.5%
2%
0%
Brozovich et al. [19]
63
22
Not mentioned
Not mentioned
Not mentioned
Adler et al. [20]
79
16
37%
Not mentioned
3%
As mentioned in the introduction, Brigic et al. [6] compared outcomes following segmental colectomy for benign and malignant colonic polyps. The fact that colectomy for benign disease was shown to cause significant morbidity in at least one-third of patients in their study should in their opinion provide further impetus to develop alternative, less invasive treatment options for this growing group of patients.
Particularly after open surgery, it is very undesirable to reoperate a patient to perform a completion lymphadenectomy after limited surgery for a presumed benign polyp.
Currently, given the laparoscopic skills of surgeons and improving recognitions of benign neoplasms of endoscopists a less invasive, laparoscopic-endoscopic rendezvous procedure could be a more favorable approach. In this procedure, the colonic segment containing the polyp can be laparoscopically manipulated to achieve better intraluminal exposure of the polyp. The endoscopic removal is with strict laparoscopic visualization of the serosal aspect of the polypectomy area, which allows any subtle change to be recognized and repaired if needed. For lesions inaccessible for endoscopic removal, a small colectomy for resection of the polyp or an endoscopy-assisted wedge resection could be performed [2224]. It has to be determined whether these more limited procedures are associated with lower morbidity and mortality rates, shortened length of hospital stay and the advantage of preservation of the colon.
In this laparoscopic era, a completion lymphadenectomy within 2 weeks seems very feasible. If laparoscopic local excision would be an option rather than an oncological resection, only 6.6% of patients would need a reoperation for lymph node sampling and 93.4% would be spared a partial oncological colectomy.
Obviously the present study is limited by its retrospective design and relatively small numbers. Another limitation is the partially subjective nature of determining whether a polyp is endoscopically unresectable. However, all cases were discussed before surgery at a weekly multidisciplinary gastrointestinal oncology meeting.
The strength of the study is that it is a consecutive series from a single, non-academic, non-referral center, reflecting daily clinical practice and the correlation of pathological findings to clinical outcome. To our knowledge, this is the first study to report the increase in patients with benign polyps referred for surgery after implementation of a national bowel screening program.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by the authors.
For this type of study formal consent is not required.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
2.
Zurück zum Zitat Winawer SJ, Zauber AG, Ho MN et al (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The national polyp study workgroup. N Engl J Med 329:1977–1981CrossRefPubMed Winawer SJ, Zauber AG, Ho MN et al (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The national polyp study workgroup. N Engl J Med 329:1977–1981CrossRefPubMed
3.
Zurück zum Zitat Zauber AG, Winawer SJ, O’Brien MJ et al (2012) Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366:687–696CrossRefPubMedPubMedCentral Zauber AG, Winawer SJ, O’Brien MJ et al (2012) Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366:687–696CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Logan RFA, Patnick J, Nickerson C et al (2012) Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut 61(10):1439–1446CrossRefPubMed Logan RFA, Patnick J, Nickerson C et al (2012) Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut 61(10):1439–1446CrossRefPubMed
5.
Zurück zum Zitat Longo WE, Vorgo KS, Johnson FE et al (2000) Risk factors for morbidity and mortality after colectomy for colon cancer. Dis Colon Rectum 43:83–91CrossRefPubMed Longo WE, Vorgo KS, Johnson FE et al (2000) Risk factors for morbidity and mortality after colectomy for colon cancer. Dis Colon Rectum 43:83–91CrossRefPubMed
6.
Zurück zum Zitat Brigic A, Cahill RA, Bassett P, Clark SK, Kennedy RH (2014) A prospective case controlled study of the short term outcome following hemicolectomy for benign compared with malignant colonic polyps. Colorectal Dis 16(3):179–185CrossRefPubMed Brigic A, Cahill RA, Bassett P, Clark SK, Kennedy RH (2014) A prospective case controlled study of the short term outcome following hemicolectomy for benign compared with malignant colonic polyps. Colorectal Dis 16(3):179–185CrossRefPubMed
7.
Zurück zum Zitat Kehlet H, Wilmore DW (2008) Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg 248:189–198CrossRefPubMed Kehlet H, Wilmore DW (2008) Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg 248:189–198CrossRefPubMed
8.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Lee TJ, Pascall G, Wood T et al (2009) Colonic polyps are different in the UK Bowel Cancer Screening Programme population compared to the symptomatic population. Gastrointest Endosc 69(AB290–1):3 Lee TJ, Pascall G, Wood T et al (2009) Colonic polyps are different in the UK Bowel Cancer Screening Programme population compared to the symptomatic population. Gastrointest Endosc 69(AB290–1):3
10.
Zurück zum Zitat Harrow P, Nayagam S, Stafford N et al (2001) A comparison of incidence of colorectal cancer and polyps in Bowel Cancer Screening Programme patients with symptomatic patients referred under 2 week wait in a demographically matched population. Gut 60:A114CrossRef Harrow P, Nayagam S, Stafford N et al (2001) A comparison of incidence of colorectal cancer and polyps in Bowel Cancer Screening Programme patients with symptomatic patients referred under 2 week wait in a demographically matched population. Gut 60:A114CrossRef
11.
Zurück zum Zitat Kudo S, Tamura S, Nakajima T, Yamano H, Kusaka H, Watanabe H (1996) Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest Endosc 44:8–14CrossRefPubMed Kudo S, Tamura S, Nakajima T, Yamano H, Kusaka H, Watanabe H (1996) Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest Endosc 44:8–14CrossRefPubMed
12.
Zurück zum Zitat Akintoye E, Kumar N, Aihara H et al (2016) Colorectal endoscopic submucosal dissection: a systematic review and meta-analysis. Endosc Int Open 4(10):E1030–E1044CrossRefPubMedPubMedCentral Akintoye E, Kumar N, Aihara H et al (2016) Colorectal endoscopic submucosal dissection: a systematic review and meta-analysis. Endosc Int Open 4(10):E1030–E1044CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Bertelson NL, Kalkbrenner KA, Merchea A et al (2012) Colectomy for endoscopically unresectable polyps: how often is it cancer? Dis Colon Rectum 55(11):1111–1116CrossRefPubMed Bertelson NL, Kalkbrenner KA, Merchea A et al (2012) Colectomy for endoscopically unresectable polyps: how often is it cancer? Dis Colon Rectum 55(11):1111–1116CrossRefPubMed
14.
Zurück zum Zitat Loungnarath R, Mutch MG, Birnbaum EH, Read TE, Fleshman JW (2010) laparoscopic colectomy using cancer principles is appropriate for colonoscopically unresectable adenomas of the colon. Dis Colon Rectum 53(7):1017–1022CrossRefPubMed Loungnarath R, Mutch MG, Birnbaum EH, Read TE, Fleshman JW (2010) laparoscopic colectomy using cancer principles is appropriate for colonoscopically unresectable adenomas of the colon. Dis Colon Rectum 53(7):1017–1022CrossRefPubMed
15.
Zurück zum Zitat Hauenschild L, Bader FG, Laubert T et al (2009) Laparoscopic colorectal resection for benign polyps not suitable for endoscopic polypectomy. Int J Colorectal Dis 24(7):755–759CrossRefPubMed Hauenschild L, Bader FG, Laubert T et al (2009) Laparoscopic colorectal resection for benign polyps not suitable for endoscopic polypectomy. Int J Colorectal Dis 24(7):755–759CrossRefPubMed
17.
Zurück zum Zitat Benedix F, Köckerling F, Lippert H, Scheidbach H (2008) Laparoscopic resection for endoscopically unresectable colorectal polyps: analysis of 525 patients. Surg Endosc 22(12):2576–2582CrossRefPubMed Benedix F, Köckerling F, Lippert H, Scheidbach H (2008) Laparoscopic resection for endoscopically unresectable colorectal polyps: analysis of 525 patients. Surg Endosc 22(12):2576–2582CrossRefPubMed
18.
Zurück zum Zitat Zmora O, Benjamin B, Reshef A et al (2009) Laparoscopic colectomy for colonic polyps. Surg Endosc 23(3):629–632CrossRefPubMed Zmora O, Benjamin B, Reshef A et al (2009) Laparoscopic colectomy for colonic polyps. Surg Endosc 23(3):629–632CrossRefPubMed
19.
Zurück zum Zitat Brozovich M, Read TE, Salgado J, Akbari RP, McCormick JT, Caushaj PF (2008) Laparoscopic colectomy for apparently benign colorectal neoplasia: a word of caution. Surg Endosc 22(2):506–509CrossRefPubMed Brozovich M, Read TE, Salgado J, Akbari RP, McCormick JT, Caushaj PF (2008) Laparoscopic colectomy for apparently benign colorectal neoplasia: a word of caution. Surg Endosc 22(2):506–509CrossRefPubMed
20.
Zurück zum Zitat Alder AC, Hamilton EC, Anthony T, Sarosi GA Jr (2006) Cancer risk in endoscopically unresectable colon polyps. Am J Surg 192(5):644–648CrossRefPubMed Alder AC, Hamilton EC, Anthony T, Sarosi GA Jr (2006) Cancer risk in endoscopically unresectable colon polyps. Am J Surg 192(5):644–648CrossRefPubMed
21.
Zurück zum Zitat Van Leersum NJ, Snijders HS, Henneman D et al (2013) The Dutch surgical colorectal audit. Eur J Surg Oncol 39(10):1063–1070CrossRefPubMed Van Leersum NJ, Snijders HS, Henneman D et al (2013) The Dutch surgical colorectal audit. Eur J Surg Oncol 39(10):1063–1070CrossRefPubMed
22.
Zurück zum Zitat Nakajima K, Sharma SK, Lee SW, Milsom JW (2016) Avoiding colorectal resection for polyps: is CELS the best method? Surg Endosc 30(3):807–818CrossRefPubMed Nakajima K, Sharma SK, Lee SW, Milsom JW (2016) Avoiding colorectal resection for polyps: is CELS the best method? Surg Endosc 30(3):807–818CrossRefPubMed
23.
Zurück zum Zitat Wdinter H, Lang RA, Spelsberg FW, Jauch KW, Hüttl TP (2007) Laparoscopic colonoscopic rendezvous procedures for the treatment of polyps and early stage carcinomas of the colon. Int J Colorectal Dis 22(11):1377–1381CrossRef Wdinter H, Lang RA, Spelsberg FW, Jauch KW, Hüttl TP (2007) Laparoscopic colonoscopic rendezvous procedures for the treatment of polyps and early stage carcinomas of the colon. Int J Colorectal Dis 22(11):1377–1381CrossRef
24.
Zurück zum Zitat Jang JH, Kirchoff D, Holzman K et al (2013) Laparoscopic-facilitated endoscopic submucosal dissection, mucosal resection, and partial circumferential (“wedge”) colon wall resection for benign colorectal neoplasms that come to surgery. Surg Innov 20(3):234–240CrossRefPubMed Jang JH, Kirchoff D, Holzman K et al (2013) Laparoscopic-facilitated endoscopic submucosal dissection, mucosal resection, and partial circumferential (“wedge”) colon wall resection for benign colorectal neoplasms that come to surgery. Surg Innov 20(3):234–240CrossRefPubMed
Metadaten
Titel
The impact of the national bowel screening program in the Netherlands on detection and treatment of endoscopically unresectable benign polyps
verfasst von
C. C. M. Marres
C. J. Buskens
E. Schriever
P. C. M. Verbeek
M. W. Mundt
W. A. Bemelman
A. W. H. van de Ven
Publikationsdatum
17.11.2017
Verlag
Springer International Publishing
Erschienen in
Techniques in Coloproctology / Ausgabe 11/2017
Print ISSN: 1123-6337
Elektronische ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-017-1705-x

Weitere Artikel der Ausgabe 11/2017

Techniques in Coloproctology 11/2017 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.